Is nitazoxanide an effective treatment for patients with acquired immune deficiency syndrome-related cryptosporidiosis? Commentary

Nature Clinical Practice Gastroenterology and Hepatology

Volumn 4, Issue 3, 2007, Pages 136-137

  Sears, Cynthia L ^a   Kirkpatrick, Beth D ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF VERMONT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIARRHEAL AGENT; NITAZOXANIDE; PLACEBO; ROTAVIRUS VACCINE;

AIDS PATIENT; AIDS RELATED COMPLEX; CLINICAL ASSESSMENT; CLINICAL TRIAL; CRYPTOSPORIDIOSIS; DEVELOPING COUNTRY; DRUG APPROVAL; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG INDICATION; DRUG RESPONSE; DRUG SAFETY; FOOD AND DRUG ADMINISTRATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PATIENT SELECTION; PHYSICAL EXAMINATION; PRIORITY JOURNAL; QUESTIONNAIRE; SHORT SURVEY; TREATMENT DURATION; UNITED STATES;

EID: 33947232351     PISSN: 17434378     EISSN: 17434386     Source Type: Journal    
DOI: 10.1038/ncpgasthep0737     Document Type: Short Survey

References (5)

1. Guerrant DI et al. (1999) Association of early childhood diarrhea and cryptosporidiosis with impaired physical fitness and cognitive function four to seven years later in a poor urban community in northeast Brazil. Am J Trop Med Hyg 61: 707-713
2. Kirkpatrick BD et al. (2002) Cryptosporidiosis stimulates an inflammatory intestinal response in malnourished Haitian children. J Infect Dis 186: 94-101
3. Agnew DG et al. (1998) Cryptosporidiosis in northeastern Brazilian children: Association with increased diarrhea morbidity. J Infect Dis 177: 754-760
4. Manabe YC et al. (1998) Cryptosporidiosis in patients with AIDS: correlates of disease and survival. Clin Infect Dis 27: 536-542
5. Ruiz-Palacios GM et al. (2006) Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 354: 11-22